The intestine is an 'invironment', a shared space where the interior and the exterior of the organism merge. The complexity of the intestinal microbiome modulates such interaction, and reflects the coordinated evolution of animals and intestinal microbes. The intestinal microbiome is exposed to the environmental resistome, to intestinal organisms from other hosts and also to microbiome-damaging agents, such as antibiotics. The result is a 'genetic-genomic-metagenomic reactor' where resistance genes flow among different biological units of different hierarchical levels, such as integrons, transposons, plasmids, clones, species or genetic exchange communities. Metagenomics provides the possibility to explore the presence of antibiotic resistance genes in all these biological and evolutionary units, and to identify possible 'high risk associations'. Multi-layered metagenomic epidemiology is required to understand and eventually to predict and apply interventions aiming to limit antibiotic resistance. The intestinal microbiota, the last organ to be deciphered in the human body Humans (as all other animals or plants) are not only constituted by their species-specific cells. The human body is a consortium of human and bacterial cells, and human physiological (and may be behavioural) features are a result of this consortium. In terms of genetic information, the number of genes in the intestinal microbiota (more than 3 million unique genes overall) outweighs by 150 times the number of genes in the human genome [2] . This means that the idea of a human body that was subsequently colonized by microbes is simply a biological mistake. The intestinal microbiota is a real organ, a half-external organ of our economy. A human without its intestinal microbiota is simply not a metabolically viable human and is an environmentally incompatible structure prone to extinction. What we know is that our intestinal microbiota is extremely complex in terms of bacterial groups and integrated
The intestine as an 'invironment'
The intestine is a duct crossing the deepest intimacies of the body of humans and animals, physically open to the external environment at both of its extremes and to the interior of the body by a multitude of interactive sites. It could be well defined as an 'invironment', borrowing Michael Bell's expression [1] , i.e. a shared space where the interior and the exterior of organisms merge, in other words an endogenized external environment. The intestine concentrates the highest density of human chemical and biological interactions with the living environment, and such interactions are mainly represented and managed throughout the intestinal microbiota.
The intestinal microbiota, the last organ to be deciphered in the human body Humans (as all other animals or plants) are not only constituted by their species-specific cells. The human body is a consortium of human and bacterial cells, and human physiological (and may be behavioural) features are a result of this consortium. In terms of genetic information, the number of genes in the intestinal microbiota (more than 3 million unique genes overall) outweighs by 150 times the number of genes in the human genome [2] . This means that the idea of a human body that was subsequently colonized by microbes is simply a biological mistake. The intestinal microbiota is a real organ, a half-external organ of our economy. A human without its intestinal microbiota is simply not a metabolically viable human and is an environmentally incompatible structure prone to extinction. What we know is that our intestinal microbiota is extremely complex in terms of bacterial groups and integrated interactions, and such complexity is featuring the stability and probably the reproduction of the microbiota.
Ontogeny and phylogeny of the intestinal microbiota
Of course, as in the case of other organs, there should be an ontogeny and a phylogeny of intestinal microbiota, certainly a key area for future research. Starting from the consideration of microbiotic ontologies, the first theoretical and bioinformatic steps in this direction have been proposed [3, 4] . The anatomy and physiology of the intestine in different animals, from nematodes to mammals, are shaped by the interactions of the host with the microbiota, so there is certainly a microbiota-host coevolution that has been scarcely considered in evolution [5] . How microbiota diversification correlates with geographical diversification during evolution has also started to be explored by studying extinct human microbiomes [6] . Where did the bacterial organisms from the intestinal microbiota originate? And which are the biological rules that apply to build up the extreme complexity of the microbiota composition not only during evolutionary times but also in each individual host? What we know is that the intestinal microbiota is reproducible, transmitted to the progeny and close relatives; in a sense, it multiplies itself as a collective biological individual. As far as their possible evolutionary origins, it is tempting to suggest that every organism in the intestinal microbiota had an ancestor in the environmental microbial systems, and that bacterial communities degrading organic residues in the soil, or providing symbiotic effects in plants, might constitute ancestor communities for the primitive intestinal microbiota in early Enterozoa. Recent holistic approaches such as the Earth Microbiome Project might eventually cast some light on these points [7] .
The intestinal microbiota is exposed to the environmental resistome
The intestine is an open system, exposed to the influences of the myriad of daily bacterial acquisitions from environmental microbes, including the microbiomes of other members of the same species, from other species and from food, water or soil. Many members of these incoming bacteria are harbouring antibiotic resistance genes. For instance, 7% of the isolates among a sample of 480 soil Streptomyces were able to detoxify macrolide antibiotics in culture media [8???] . Many antibiotic resistance genes evolve from chromosomal genes encoding housekeeping functions, primarily unrelated to any antibiotic resistance phenotype [9] . Metagenomic analysis of intestinal microbiota has revealed an unexpected wealth of different b-lactamases, most of them unknown in culturable bacterial pathogens [10] . These authors found CTX-M enzymes both in metagenomic samples and in bacterial culturable commensal pathogens, but, unexpectedly, failed to find in metagenomes frequent b-lactamases present in Enterobacteriaceae, such as the apparently ubiquitous TEM-derived or AmpC enzymes. At present it is difficult to deduce the physiological function of these known (e.g. CTX-M) or unknown metagenomic b-lactamases, but of course protection of the normal commensals towards b-lactam antimicrobials cannot be discarded. It could be interesting to investigate the environmental origin of these inactivating enzymes. For instance, CTX-M enzymes are chromosomal genes in soil-water bacteria such as Kluyvera [11] .
The environmental microorganismsintestinal microbiota interaction
How these resistance-encoding genes enter into bacterial species able to produce infections in humans has been a hot topic of research during the last few years. Mobilization, i.e. gene capture, probably occurs mainly by insertion sequences harboured by transposons or plasmids [12] . The process of direct acquisition of genes from environmental bacteria by gut intestinal commensals could be constrained by the cell density required for the transient donors. On the other hand, antibiotic exposure might favour such types of events to a certain extent. The risk of fusing ecological compartments such as soil and human intestinal microbiota in sewage and sludge has been pointed out. Certainly it is difficult to believe that public health officers and ecotoxicologists have failed for more than a century to seriously propose the absolute need to prevent the mix between microorganisms from human-animal and environmental compartments [13] . In conditions of water sewage antibiotic contamination, the acquisition of resistance genes might be favoured. It should be noted that, although conventional biological wastewater treatment processes are effective for the removal of some antibiotics, many antibiotics have been reported to occur at 10-1000 ng/L in secondary treated effluents, including b-lactams, sulfonamides, trimethoprim, macrolides, fluoroquinolones and tetracyclines [14] .
Metagenomic populations of transhierarchical evolutionary individuals
Metagenomics literally means 'beyond the genome' [15] . Metagenomics is a critical tool to study the laws of conversion from evolutionary 'pieces' (evolutionary individuals) into 'patterns' (selectable ensembles of individuals) [16] . A key issue in future metagenomic epidemiology is the need to target sequences able to detect changes in evolutionary individuals, 'beyond the genome'. But what is an evolutionary individual? An individual is both a replicator (a reproducing entity) and a variator (let us borrow this term from engineering and computer sciences). All entities that reproduce and are submitted to variation are evolutionary individuals (evolutionary units), with potential to be hooked by natural selection. The levels of selection approach [17] considers whether natural selection operates on evolutionary individuals at different levels of complexity, such as genetic sequences, genes, operons, mobile genetic elements (MGEs) (such as plasmids or transposable elements), genomes, organisms, clones, groups, species, communities or ecosystems. In this perspective, an individual is any entity that, independently from the number of elements that enters into its composition or from its hierarchical complexity, is selected as a unit. The elements that compose an individual might be in their turn individuals, and therefore able to be selected as units. Of course, individuals are grouped in populations. Populations are composed of individuals, are groups of individuals linked by common patterns of genetic (evolutionary cohesion) and demographic (ecological cohesion) connectivity, i.e. differing by descent and spatial location from other populations [18] .
Metagenomic evolutionary units involved in antibiotic resistance
The emergence and spread of antibiotic resistance is determined by sequences in resistance genes, but also by the genetic structure in which these genes are placed (as integrons) and the MGEs where these elements are able to disseminate (such as plasmids, phages, transposons or integrative-conjugative elements). In their turn, the maintenance or spread of these MGEs depends on their localization in clones or clonal complexes within species, but also on the connectivity of these species with other species, i.e. in their possible spread within genetic exchange bacterial communities. The establishment and evolution of these communities depends also on the entire microbiotic context. Because of that, a multi-layered metagenomic epidemiology approach is required to understand and eventually to predict and apply interventions aiming to limit antibiotic resistance. As we shall see later, such an approach is starting to be applied in a systematic way in the study of particular resistance problems but it remains essentially based on culturable organisms, requires an extensive amount of work, and probably fails to detect essential characters in the plot. To circumvent these difficulties, a metagenomic analysis is required.
Such a metagenomic analysis should take into consideration the following.
1 A general metagenomic profiling of the abundant taxa and species present in the microbiota. Very little is known about how differences in large taxa-species microbiotic profiles might influence antibiotic resistance, particularly under conditions of antibiotic exposure or in situations where full integrity of the microbiotic system might be immature, degraded or damaged, as in the newborns, elderly people, people with nutritional deficiency, and patients with anatomical or physiological alterations that might influence the intestinal environment. 2 The metagenomic identification of the existence and composition of groups of species that form genetic exchange communities [19] where particular MGEs and resistance genes might preferentially circulate. Note that these communities are made up by both commensal and potentially pathogenic strains, and are expected to be key elements for the maintenance of antibiotic resistance genes. 3 The metagenomic identification of particular species and clones of particular interest in antibiotic resistance, mainly bacterial pathogens. If species identification is relatively easy (based for instance on ribosomal DNA sequences), a more difficult metagenomic task that requires attention is the identification of particular clones within species, in particular the detection of socalled 'high risk clones or clonal complexes', referring to highly specialized genetic populations or subpopulations with enhanced ability to colonize, spread and persist in particular niches after having acquired a diversity of adaptive traits that increase their epidemicity and/or pathogenic potential, including antibiotic resistance. These clones, replacing the more heterogeneous antibiotic-susceptible ones, become 'amplificators' of antimicrobial resistance [20] .
4 The identification of the subcellular metagenomic mobilome, i.e. identification of MGEs involved in the spread of antibiotic resistance. Of course we can apply different observational levels. A general 'plasmidome' profiling can be followed by identification of more precise plasmid groups, based on Rep, Rel or TA sequences [21] . Similarly, we need a general metagenomic profiling of phages, transposons and integrative-conjugative elements, and more specific detection of the different particular elements, for instance Tn21-type transposons. That should be complemented by a general metagenomic profiling of integrons and specific detection of particular integrons. 5 Finally, a gene-based metagenomic analysis could be focused just on sequences, genes or groups of genes, such as operons, regulatory genes, genes or sequences involved in the capture of other genes, including resistance genes. Appropriate specific or degenerate sequences will be able to shape the orthology of the targeted genes, as detection of orthologues, homologues or paralogues [22] .
For the purposes of the main message of this work, the important point is that these five metagenomic approaches are applied at different levels of the microbiome complexity, identifying distinct evolutionary individuals at each hierarchical level.
The metagenomic dynamics of evolutionary units: the four Ps
Epidemiology shares with evolution the interest in detecting the variations in the frequency of and tracing the changes in the associations of the target epidemiological or evolutionary units. Both the variations in frequency and the emerging changes or associations in antibiotic resistance depend on the construction of interactive networks able to exchange resistance genes between communities, groups of species, organisms, and/or among MGEs and their platforms. In fact knowledge of how these changes and associations occur might eventually offer some insights to predict evolutionary trajectories and to apply appropriate interventions [23] . For that purpose, the distinction of a number of key properties applicable in every kind of evolutionary unit is needed. At any level of the hierarchy (let us say, from clones to plasmids or genes), the ecology and evolution of antimicrobial resistance depends on the 'four Ps': penetration, promiscuity, plasticity and persistence of the different genetic units [24] (Fig. 1) .
Penetration is used here, by analogy with the term used in security engineering, for elements having a high attack profile regarding existing networks and refers to the ability of a genetic element from a particular system to enter and be present in other systems. Examples are bacterial clones able to efficiently colonize and spread in microbiomes of different hosts, or broad-host-range plasmids disseminating in widely different bacteria.
Promiscuity refers to the ability not only to enter and be present in other systems but to exchange genetic sequences with the members of these systems.
Plasticity is applied here as tolerated variability in the genetic sequences, from changes in the sequence of nucleotides in a gene, to changes in the order of genes in a genome (syntheny) or changes in the modular structure of genetic regions (modularity) or in the modulation of their expression. An example of this is the change in the order of gene cassettes within a particular integron.
Persistence is the ability for 'niche construction' of each one of the biological elements, so that permanent links with their surrounding environment (including the genetic context) are established, allowing long-term coexistence or fixation of the sequence or element in the system.
Metagenomics in predicting antibiotic resistance
Prediction of the behaviour of highly complex systems is a difficult task, particularly very early (birth of a new resistance gene, gene capture and establishment) and long-term and global predictions (gene spread and evolution among bacterial populations). In these cases, the occurrence and frequency of evolutionary events are either stochastic or present an indescribable level of variability, so that theoretical predictions are probably impossible with our current tools. Possible ways of approaching prediction is to work with data obtained in experimental studies with natural populations, or to apply multi-level genetic epidemiology in early observations of emerging resistance [25] . In the first case, a diversity of natural bacterial communities (such as human or animal microbiota) should be exposed, either in vitro (microcosms) or in vivo, on the occasion of clinical trials or antibiotic challenge in experimental farms. High-throughput metagenomic screening of antibioticselected bacterial groups might provide early data about the possibilities of emergence and selection of particular resistance genes, and eventually of the MGEs and bacterial groups in which resistance is expected to occur. Of course negative results are scarcely predictive, as experimental studies are only possible with a limited number of samples. Surveillance networks for early antibiotic resistance could provide more solid predictive clues [26, 27] . A multi-layered epidemiological strategy based on metagenomics should be applied in these studies, trying to characterize simultaneously the resistance genes, the genetic platforms in which they are located (as integrons), the transposable elements harbouring such platforms, the plasmids eventually carrying them, and at supracellular level the bacterial clones, species and communities in which the resistance gene occurs (Fig. 2) . These studies are currently carried out in focused, hard work-load studies by more conventional methods [28] [29] [30] .
A certain contribution to the integrated risk of spreading resistance might be attributed at each of these levels, but we are far from being able to provide quantitative assessments and hence a real prediction of resistance spread and its future evolutionary trajectories. Heuristic techniques are being considered for the understanding of multi-level selection in the presence or absence of antibiotics, based on covariance, and contextual analysis, for instance using Price's equation [31] , which might open an entirely new synthetic way of approaching prediction of antibiotic resistance.
A metagenomic registry of evolutionary units involved in antibiotic resistance (EVUARS)
A natural milestone of metagenomic studies devoted to antibiotic resistance should be the construction of a cataloguerepositorium, a registry of evolutionary units for antibiotic resistance (EVUARs) from DNA sequences and genes to microbial communities. In a first step such a catalogue could be based on the most immediate environment ('invironment', see above), the intestinal microbiota, but, as has been stated before, antibiotic resistance is also an ecological problem, influenced by alterations in the global environment [32] . This approach requires (i) a collection of EVUAR profiles in different locations, from the intestine of humans and animals to sludge, sewage or soil under different selective or environmental conditions (antibiotic exposure, industrial residues exposure, climate); (ii) a collection of EVUAR association patterns-how different evolutionary units associate statistically and how these associations evolve in time; (iii) the study of the conditions that might explain these covariances; and (iv) in silico, in vitro and in vivo modelization procedures to reproduce the observed associations. These studies might follow, at least in part, preceding initiatives about 'registries of standard biological parts' that are starting to be used in synthetic biology research [33, 34] .
Metagenomics for surveillance and intervention: eco-evo approaches
The evolutionary units involved in antibiotic resistance that metagenomic studies might reveal are in fact the natural units for surveillance of antibiotic resistance. Surveillance should be applied for changes in the frequency of the units, and particularly for changes in the correlated frequency of the units or evolutionary individuals, considering the different hierarchical levels of biological complexity. Such changes might reveal dangerous evolutionary ensembles moving along high risk evolutionary trajectories. Of course specific interventions could be designed targeting specific key elements involved in these processes. The need of focused research to find drugs and strategies aiming to counteract the above-mentioned 'four Ps', penetration, promiscuity, plasticity and persistence of evolutionary units such as bacterial clones, MGEs or resistance genes, has recently been suggested [24] . The term 'drug' is used in this eco-evo perspective as a tool to fight resistance that is able to prevent, cure or decrease potential damage caused by antibiotic resistance, not necessarily only at the individual level (the patient) but also at the ecological and evolutionary levels. Eco-evo drugs and interventions constitute a new avenue for research that might influence not only antibiotic resistance but the maintenance of a healthy interaction between humans and microbial systems in a rapidly changing environment. Such an ambitious approach will be unimaginable in the absence of metagenomics, but its consequences might provide the tools for shaping and correcting the undesirable deviations of the microbiosphere and their perverse consequences for human and Earth health, as the novel perspectives in 'one health-one medicine' and consequently in advanced public health microbiology require [35, 36] .
